Leishmaniasis in a patient with liver cirrhosis;Leishmaniasis en paciente con cirrosis hepática

Anales de Medicina Interna

Volumn 20, Issue 3, 2003, Pages 145-147

  De Diego Lorenzo, A ^a   Banares R ^a   Catalina, V ^a   Garcia Sanchez A ^a   Barrio, J ^a   Clemente, G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Fever; Leishmaniasis; Liver cirrhosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEVER; HUMAN; LEISHMANIASIS; LIVER CIRRHOSIS; MALE;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMONY SODIUM GLUCONATE; HUMANS; LEISHMANIA; LEISHMANIASIS; LIVER CIRRHOSIS; LIVER DISEASES, PARASITIC; MALE; TREATMENT OUTCOME;

EID: 0037362145     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Guarner C, Soriano G. Factores predisponentes de las infecciones bacterianas en la cirrosis hepática. Gastro'98, Ed. Acción Médica SA, Madrid, 1998: 205-11.
2. Clemente G, Barajas JM, Serrano MI, et al. Infecciones bacterianas en la cirrosis hepática. Gastroenterol Hepatol 1986; 9: 291-3.
3. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986; 6: 252-6.
4. DeMeo AN, Andersen BR. Defective chemotaxis associated with serum inhibition in cirrhotic patients. N Engl J Med 1972; 286: 735-40.
5. Rabinovitz M, Gavaler JS, Kumar S, et al. Role of serum complement, immunoglobulins, and cell-mediated immune system in the pathogenesis of spontaneous bacterial peritonitis (SBP). Dig Dis Sci 1989; 34: 1547-52.
6. Rimola A, Soto R, Bory F et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.
7. O Keefe SJ, El-Zayadi AR, Carrhaher TE, et al. Malnutrition and immunoincompetence in patients with liver disease. Lancet 1980; 2: 615-7.
8. Ramoa A, Portero JL, Gazapo T, et al. Visceral leishmaniasis in immunocompromised patients. An Med Interna (Madrid) 1998; 15: 301-4.
9. Hernández Pérez J, Yebra Bango M, Jiménez Martínez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999; 29: 918-21.
10. Guardia J, Fraiha HN, Miles MA. Leihmaniasis y tripanosomiasis. En: Verger Garau G. Enfermedades Infecciosas. Ed. Doyma SA, Barcelona 1988: 410-4.
11. El Hag IA, Hashim FA, El Toum IA, et al. Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol 1994; 47: 547-51.
12. Corbett CE, Duarte MI, Bustamante SE. Regression of diffuse intralobular liver fibrosis associated with visceral leishmaniasis. Am J Trop Med Hyg 1993; 49: 616-24.
13. Bryceson ADM. Leishmaniasis visceral. En: Rodés J, Benhamou JD, Bircher J et al. Tratado de Hepatologia Clinica. Ed. Científicas y Técnicas SA. Barcelona 1993: 821-6.
14. Prasad LS. Kala azar. Indian J Pediatr 1999; 66: 539-46.
15. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-9.
16. Buyukasik Y, Ileri NS, Haznedaroglu IC, et al. Fever, hepatosplenomegaly and pancytopenia in a patient living in the Mediterranean region. Postgrad Med J 1998; 74: 237-9.
17. Aggarwal P, Wali JP, Chopra P. Liver in kala-azar. Indian J Gastroenterol 1990; 9: 135-6.
18. Duarte MI, Mariano ON, Corbett CE. Liver parenchymal cell parasitism in human visceral leishmaniasis. Virchows Arch A Pathol Anat Histopathol 1989; 415: 1-6.
19. Khaldi F, Bennacem B, Othaman HB, et al. Les formes severes d'atteinte hepatique an cours de la leichmaniose viscerale. A propos de 7 cas. Arch Fr Pediatr 1990; 47: 257-60.
20. Fernández-Miranda C, Colina F, Delgado JM, et al. Diffuse nodular hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis. Am J Gastroenterol 1993; 88: 433-5.
21. Moreno A, Marazuela M, Yebra M, et al. Hepatic fibrin-ring granulomas in visceral leishmaniasis. Gastroenterology 1988; 95: 1123-6.
22. Medina Pérez M, Jiménez Gonzólez F, Marín Martín J. Leishmaniasis en el bloque celular del aspirado de médula ósea. An Med Interna (Madrid) 2000; 17: 72-3.
23. Boelaert M, Dujardin JC. Diagnosis PCR with Leishmania donovani specificity. Trop Med In Health 1999; 4: 789.
24. Lachaud L, Dereure J, Chabbert E, et al. Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients. J Clin Microbiol 2000; 38: 236-40.
25. Singh UK. Diagnosis and management of Kala azar. Indian Pediatr 1999; 36: 231-6.
26. Aggarwal P, Handa R, Singh S, Wali JP. Kala azar new developments in diagnosis and treatment. Indian J Pediatr 1999; 66: 63-71.
27. Gangneux JP. Treatment of visceral leishmaniasis: recent modalities. Presse Med 1999; 28: 2057-66.